TITAN PHARMACEUTICALS INC Logo

TITAN PHARMACEUTICALS INC

Develops a long-term drug delivery implant for treating chronic central nervous system disorders.

TTNP | US

Overview

Corporate Details

ISIN(s):
US8883146065
LEI:
Country:
United States of America
Address:
400 OYSTER POINT BLVD, 94080 SAN FRANCISCO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Titan Pharmaceuticals, Inc. is a development-stage biopharmaceutical company that develops proprietary therapeutics for the treatment of select chronic diseases. The company's core technology is its clinically proven ProNeura® platform, a long-term, continuous drug delivery system. This platform is designed to deliver stable, non-fluctuating levels of medication for periods of up to one year from a single subcutaneous implant. Titan's research and development activities are focused on exploring new therapeutic applications for the ProNeura platform, with a primary emphasis on treating central nervous system disorders. In late 2023, the company announced a merger with Black Titan Corporation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all TITAN PHARMACEUTICALS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TITAN PHARMACEUTICALS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TITAN PHARMACEUTICALS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

TG THERAPEUTICS, INC. Logo
Commercializes B-cell therapies like BRIUMVI® for multiple sclerosis & autoimmune diseases.
United States of America
TGTX
Tharimmune, Inc. Logo
Clinical-stage biotech developing therapies for immunology, oncology, & opioid effects.
United States of America
THAR
Theradiag Logo
Develops IVD tests for biotherapy monitoring in autoimmune diseases and oncology.
France
ALTER
THERAGEN ETEX CO.,LTD. Logo
A biotech firm offering gene analysis and developing personalized cancer drugs.
South Korea
066700
Theranexus Logo
A biopharma developing drugs for rare neurological diseases by targeting non-neuronal cells.
France
ALTHX
Theratechnologies Inc. Logo
Biopharma company commercializing therapies for multi-drug resistant HIV and lipodystrophy.
United States of America
THTX
Theravance Biopharma, Inc. Logo
Developing medicines for specialty respiratory and neurologic diseases like COPD.
United States of America
TBPH
TheraVet SA Logo
Belgium
ALVET
THERMO FISHER SCIENTIFIC INC. Logo
Provider of analytical instruments, diagnostics, and pharma services for labs and clinics worldwide.
United States of America
TMO
Thor Medical ASA Logo
Sustainably produces alpha-emitters from thorium for cancer therapies, without nuclear reactors.
Norway
NANOV

Talk to a Data Expert

Have a question? We'll get back to you promptly.